文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

CD4/CD8+T 细胞、树突状细胞亚群、Foxp3 和 IDO 表达是预测胃癌预后的指标。

CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.

机构信息

Department of Radiotherapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.

Department of Cancer Prevention, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

出版信息

Cancer Med. 2019 Dec;8(17):7330-7344. doi: 10.1002/cam4.2596. Epub 2019 Oct 20.


DOI:10.1002/cam4.2596
PMID:31631566
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6885892/
Abstract

BACKGROUND: The tumor microenvironment represents an abnormal niche containing numerous factors, such as T cells, dendritic cells (DCs), regulatory T cells (Tregs), and indoleamine 2,3-dioxygenase (IDO), involved in maintaining immune homeostasis and tolerance. All these factors may influence the choice of therapy and the clinical outcomes. METHODS: Flow cytometry was performed to identify CD4+/CD8 + T cells and DCs, and immunohistochemistry was used to evaluate IDO and Forkhead Box P3 (Foxp3) expression; these experiments were performed in order to explore the clinical and prognostic significance of CD4/CD8 + T cells, DCs, Tregs, and IDO expression in gastric carcinoma. RESULTS: Smaller tumor size was correlated with higher expression levels of peripheral CD4 + T cells (P = .003) and CD8 + T cells (P = .002), and lower IDO expression (P = .044) in tumors. Well-differentiated gastric carcinomas displayed higher peripheral (P = .029) and tumor-infiltrating CD4 + T cell (P = .009) populations and a higher tumor-infiltrating DC1/DC2 ratio (P = .048). Gastric cancer in the early T stages exhibited higher populations of peripheral DC2s (P = .044) and a higher tumor-infiltrating DC1/DC2 ratio (P = .012). Gastric cancer at the N0 stage had lower tumor-infiltrating DC2s (P = .032) and a higher DC1/DC2 ratio (P = .037). IDO expression was positively correlated with tumor-infiltrating Foxp3 + Tregs (P < .001) as well as DC2s (P < .001), whereas it was negatively correlated with the tumor-infiltrating CD4/CD8 + T cell ratio (P = .023). Tumor-infiltrating Foxp3 + Treg was positively correlated with tumor-infiltrating DC2s (r  = 0.772; P < .001). At T, N, and TNM stages, the expression levels of peripheral DC2s, tumor-infiltrating DC1/DC2 ratios, Foxp3 + Tregs, and IDO were significantly correlated with prognosis (P < .05). The T stage and peripheral DC2s were significant risk factors for overall survival. CONCLUSION: Immunocompetent cells and humoral immune factors, including DC2s, CD4+/CD8 + T cells, Foxp3 + Tregs, and IDO, interact with each other to compose a complex community of tumor immune microenvironment, ultimately affecting tumor progression and survival of gastric cancer.

摘要

背景:肿瘤微环境代表了一个包含众多因素的异常生态位,如 T 细胞、树突状细胞(DCs)、调节性 T 细胞(Tregs)和吲哚胺 2,3-双加氧酶(IDO),这些因素共同参与维持免疫稳态和耐受。所有这些因素都可能影响治疗选择和临床结果。

方法:采用流式细胞术鉴定 CD4+/CD8+T 细胞和 DCs,免疫组织化学法检测 IDO 和叉头框 P3(Foxp3)的表达,探讨 CD4/CD8+T 细胞、DCs、Tregs 和 IDO 表达在胃癌中的临床和预后意义。

结果:肿瘤较小者外周血 CD4+T 细胞(P=.003)和 CD8+T 细胞(P=.002)表达较高,肿瘤中 IDO 表达较低(P=.044)。分化较好的胃癌患者外周(P=.029)和肿瘤浸润 CD4+T 细胞(P=.009)以及肿瘤浸润 DC1/DC2 比值较高(P=.048)。早期 T 期胃癌患者外周 DC2 细胞(P=.044)和肿瘤浸润 DC1/DC2 比值较高(P=.012)。N0 期胃癌患者肿瘤浸润 DC2 细胞(P=.032)和 DC1/DC2 比值较高(P=.037)。IDO 表达与肿瘤浸润 Foxp3+Tregs(P<.001)以及 DC2s(P<.001)呈正相关,与肿瘤浸润 CD4/CD8+T 细胞比值呈负相关(P=.023)。肿瘤浸润 Foxp3+Treg 与肿瘤浸润 DC2 呈正相关(r=0.772;P<.001)。在 T、N 和 TNM 分期中,外周 DC2 细胞、肿瘤浸润 DC1/DC2 比值、Foxp3+Tregs 和 IDO 的表达与预后显著相关(P<.05)。T 期和外周 DC2 细胞是总生存的显著危险因素。

结论:包括 DC2、CD4+/CD8+T 细胞、Foxp3+Tregs 和 IDO 在内的免疫细胞和体液免疫因子相互作用,构成了一个复杂的肿瘤免疫微环境共同体,最终影响胃癌的肿瘤进展和生存。

相似文献

[1]
CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.

Cancer Med. 2019-10-20

[2]
Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.

Cancer Biol Ther. 2018-5-8

[3]
The subsets of dendritic cells and memory T cells correspond to indoleamine 2,3-dioxygenase in stomach tumor microenvironment.

Tumour Biol. 2014-9

[4]
Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.

Breast Cancer Res Treat. 2017-2

[5]
ICOS Foxp3 TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori.

Int J Cancer. 2017-2-1

[6]
The Impact of Indoleamine 2,3-dioxygenase (IDO) Expression on Stage III Gastric Cancer.

Anticancer Res. 2018-6

[7]
Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.

Digestion. 2012-11-28

[8]
The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.

BMC Cancer. 2021-5-29

[9]
Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer.

J Cancer Res Clin Oncol. 2010-3-11

[10]
FOXP3+ regulatory T cells and tumoral indoleamine 2,3-dioxygenase expression predicts the carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas.

Pancreatology. 2010-11-5

引用本文的文献

[1]
Promising Gastric Cancer Biomarkers-Focus on Tryptophan Metabolism via the Kynurenine Pathway.

Int J Mol Sci. 2025-4-14

[2]
Helicobacter pylori Eradication Is Associated With a Reduced Risk of Metachronous Gastric Neoplasia by Restoring Immune Function in the Gastric Mucosa.

Helicobacter. 2025

[3]
Artificial intelligence-driven integration of single-cell RNA sequencing and transcriptome analysis to decipher APOE's role in gastric cancer prognosis and therapy.

Discov Oncol. 2025-3-13

[4]
Chromatin licensing and DNA replication factor 1 as a potential prognostic and diagnostic biomarker for gastric cancer.

Sci Rep. 2024-12-28

[5]
Construction of ferroptosis and pyroptosis model to assess the prognosis of gastric cancer patients based on bioinformatics.

Transl Cancer Res. 2024-11-30

[6]
Indoleamine 2, 3-dioxygenase Regulates the Differentiation of T Lymphocytes to Promote the Growth of Gastric Cancer Cells through the PI3K/Akt/mTOR Pathway.

Cell Biochem Biophys. 2025-6

[7]
Peripheral T Lymphocyte Predicts the Prognosis of Gastric Cancer Patients Undergoing Radical Gastrectomy: A Multicenter Retrospective Cohort Study.

J Inflamm Res. 2024-12-8

[8]
HOXC12 promotes the invasion and migration of gastric cancer cells by upregulating SALL4 and activating Wnt/β-catenin signaling pathway.

Discov Oncol. 2024-11-5

[9]
Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer.

Mol Cancer. 2024-10-30

[10]
Integrated analyses reveal IDO1 as a prognostic biomarker coexpressed with PD-1 on tumor-associated macrophages in esophageal squamous cell carcinoma.

Front Pharmacol. 2024-9-16

本文引用的文献

[1]
PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers.

Oncoimmunology. 2018-2-20

[2]
Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis.

Oncotarget. 2018-5-15

[3]
Gastric cancer patients have elevated plasmacytoid and CD1c dendritic cells in the peripheral blood.

Oncol Lett. 2018-4

[4]
Cancer statistics, 2018.

CA Cancer J Clin. 2018-1-4

[5]
Tumor-derived CD4+CD25+regulatory T cells inhibit dendritic cells function by CTLA-4.

Pathol Res Pract. 2017-3

[6]
Dendritic cells in cancer: the role revisited.

Curr Opin Immunol. 2017-4

[7]
Human Regulatory T Cells Mediate Transcriptional Modulation of Dendritic Cell Function.

J Immunol. 2017-1-1

[8]
Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis.

Mol Cancer. 2016-10-27

[9]
Prognostic impact of high levels of circulating plasmacytoid dendritic cells in breast cancer.

J Transl Med. 2016-5-28

[10]
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance.

Trends Immunol. 2016-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索